id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-255980-u0c6pg8n	Du, Lanying	Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies	2010-07-02		.txt	text/plain	3689	126	39	A virus hemagglutinin provides immunity in mice to influenza A virus challenge DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1 Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses Analysis of hemagglutininmediated entry tropism of H5N1 avian influenza Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Emergence and pandemic potential of swine-origin H1N1 influenza virus Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses Supernatants containing HA pseudovirus with or without NA were harvested 72 h post-transfection, and used for single-cycle infection.	cache/cord-255980-u0c6pg8n.txt	txt/cord-255980-u0c6pg8n.txt
